Cargando…

Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report

BACKGROUND: AATD is one of the most common inherited disorders in the World. However, it is generally accepted that AATD in North African populations is not a risk factor for lung and/or liver disease, based on a number of small studies. We therefore planned a screening study for detection of AATD i...

Descripción completa

Detalles Bibliográficos
Autores principales: Denden, Sabri, Zorzetto, Michele, Amri, Fethi, Knani, Jalel, Ottaviani, Stefania, Scabini, Roberta, Gorrini, Marina, Ferrarotti, Ilaria, Campo, Ilaria, Chibani, Jemni Ben, Khelil, Amel Haj, Luisetti, Maurizio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672056/
https://www.ncbi.nlm.nih.gov/pubmed/19368725
http://dx.doi.org/10.1186/1750-1172-4-12
_version_ 1782166465261076480
author Denden, Sabri
Zorzetto, Michele
Amri, Fethi
Knani, Jalel
Ottaviani, Stefania
Scabini, Roberta
Gorrini, Marina
Ferrarotti, Ilaria
Campo, Ilaria
Chibani, Jemni Ben
Khelil, Amel Haj
Luisetti, Maurizio
author_facet Denden, Sabri
Zorzetto, Michele
Amri, Fethi
Knani, Jalel
Ottaviani, Stefania
Scabini, Roberta
Gorrini, Marina
Ferrarotti, Ilaria
Campo, Ilaria
Chibani, Jemni Ben
Khelil, Amel Haj
Luisetti, Maurizio
author_sort Denden, Sabri
collection PubMed
description BACKGROUND: AATD is one of the most common inherited disorders in the World. However, it is generally accepted that AATD in North African populations is not a risk factor for lung and/or liver disease, based on a number of small studies. We therefore planned a screening study for detection of AATD in patients with OLD in a cohort of patients from Kairouan in central Tunisia. Methods: One hundred twenty patients with OLD (asthma, emphysema, COPD) were enrolled in the screening programme. Laboratory diagnosis for AATD was performed according to current diagnostic standards. RESULTS: We found that 6/120 OLD patients carried an AAT deficient allele, 1 PI*MZ, 1 PI*MPlowel, 3 PI*MMmalton, 1 PI*MMwurzburg. CONCLUSION: this pilot study demonstrated that alleles related to deficiency of AAT are not absent in the Tunisian population, and that rare AATD variants prevailed over commonest PI*Z variant. These results would support a larger scale screening for AATD in Tunisia.
format Text
id pubmed-2672056
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26720562009-04-23 Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report Denden, Sabri Zorzetto, Michele Amri, Fethi Knani, Jalel Ottaviani, Stefania Scabini, Roberta Gorrini, Marina Ferrarotti, Ilaria Campo, Ilaria Chibani, Jemni Ben Khelil, Amel Haj Luisetti, Maurizio Orphanet J Rare Dis Research BACKGROUND: AATD is one of the most common inherited disorders in the World. However, it is generally accepted that AATD in North African populations is not a risk factor for lung and/or liver disease, based on a number of small studies. We therefore planned a screening study for detection of AATD in patients with OLD in a cohort of patients from Kairouan in central Tunisia. Methods: One hundred twenty patients with OLD (asthma, emphysema, COPD) were enrolled in the screening programme. Laboratory diagnosis for AATD was performed according to current diagnostic standards. RESULTS: We found that 6/120 OLD patients carried an AAT deficient allele, 1 PI*MZ, 1 PI*MPlowel, 3 PI*MMmalton, 1 PI*MMwurzburg. CONCLUSION: this pilot study demonstrated that alleles related to deficiency of AAT are not absent in the Tunisian population, and that rare AATD variants prevailed over commonest PI*Z variant. These results would support a larger scale screening for AATD in Tunisia. BioMed Central 2009-04-15 /pmc/articles/PMC2672056/ /pubmed/19368725 http://dx.doi.org/10.1186/1750-1172-4-12 Text en Copyright © 2009 Denden et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Denden, Sabri
Zorzetto, Michele
Amri, Fethi
Knani, Jalel
Ottaviani, Stefania
Scabini, Roberta
Gorrini, Marina
Ferrarotti, Ilaria
Campo, Ilaria
Chibani, Jemni Ben
Khelil, Amel Haj
Luisetti, Maurizio
Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
title Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
title_full Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
title_fullStr Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
title_full_unstemmed Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
title_short Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report
title_sort screening for alpha 1 antitrypsin deficiency in tunisian subjects with obstructive lung disease: a feasibility report
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672056/
https://www.ncbi.nlm.nih.gov/pubmed/19368725
http://dx.doi.org/10.1186/1750-1172-4-12
work_keys_str_mv AT dendensabri screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT zorzettomichele screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT amrifethi screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT knanijalel screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT ottavianistefania screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT scabiniroberta screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT gorrinimarina screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT ferrarottiilaria screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT campoilaria screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT chibanijemniben screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT khelilamelhaj screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport
AT luisettimaurizio screeningforalpha1antitrypsindeficiencyintunisiansubjectswithobstructivelungdiseaseafeasibilityreport